It was the third trigger of the recession indicator in less than two weeks.Bondsread more
U.S. manufacturer growth slowed to the lowest level in almost 10 years in August, the latest sign that the trade war may be exacerbating the economic slowdown.Marketsread more
Philadelphia Fed President Patrick Harker said he doesn't see the case for additional stimulus after the Federal Reserve's July rate cut.The Fedread more
Stocks fell as fears of an economic recession built up ahead of a key speech from Federal Reserve Chairman Jerome Powell.US Marketsread more
"My sense was we've added accommodation, and it wasn't required in my view," George tells CNBC's Steve Liesman.Investingread more
Former Prudent Bear Fund manager David Tice is urging investors to brace for a massive downturn.Trading Nationread more
German Chancellor Angela Merkel said a solution to the Irish "backstop" is possible before the October 31 Brexit deadline.Europe Economyread more
Apple plans to unveil three new iPhones in September, including two new "Pro" models and a successor to the iPhone XR, Bloomberg reported Thursday.Technologyread more
A ruling against J&J could mean more big payouts in similar cases across the country.Health and Scienceread more
While Volkswagen may not want to invest in Tesla, the U.S. carmaker has been scouting locations in Europe for a new Gigafactory there.Autosread more
Corporate profits posted modest growth in the second quarter as companies brace for slowing global growth.Retailread more
Shares of health insurer Humana spiked on Friday amid reports the company had received takeover interest.
Humana—which had a market value of about $27 billion before its stock rose Friday—is working with Goldman Sachs on a potential sale, The Wall Street Journal reported, citing sources. Potential bidders for Humana include Aetna and Cigna, according to the newspaper.
Shares of the insurer jumped 19 percent Friday afternoon after a brief trading halt around 1 p.m. ET. Cigna and Aetna were up more than 4 and 2 percent, respectively.
Humana's stock had risen 23 percent this year into Friday afternoon.
Anthem seemed to be "the most likely" bidder, but Cigna and Aetna would make sense, as well, said Tom Carroll, managing director at Stifel Nicolaus. Carroll expects "a wave of consolidation" in the health-care sector.
"Our view was that Anthem and Aetna are both in a position where they must own Humana to maintain relevance long term," Carroll said in a CNBC "Closing Bell" interview.
Humana has emerged as "the big-ticket player" in Medicare, the federal program for older Americans, Carroll said. The company gets most of its sales from patients on the plan, which puts it in a key market position.
Carroll added that Humana will likely be a beneficiary of a changing Medicare landscape moving forward. Next year, he expects the first positive Medicare Advantage rate growth in about five years.
He partially attributed the rate trends to the Affordable Care Act, a key policy of President Barack Obama's administration. The ACA has boosted Humana's potential customer pool, as it requires Americans to have health insurance.
Before Friday's trading, Anthem could have fetched a price of at least $230 per share, Carroll noted. After its 19 percent jump, the shares were trading around $212.
Humana reported $34 billion in revenue last year. In the first quarter, its membership climbed to 14.2 million customers.
Humana, Anthem and Cigna did not immediately responded to requests for comment from CNBC. Aetna declined to comment.